Proactive Investors - Run By Investors For Investors

Haydale Graphene has the 'building blocks in place for growth'

Ray Gibbs, chief executive of Haydale Graphene Industries PLC (LON:HAYD), tells Proactive he's expecting revenues over the next twelve months to rise following a period of investment and expansion.

Revenues in the six months to the end of December 2017 rose by two-thirds to £2.49mln with commercial/non-grant income 85% higher at £2.04mln.

Gibbs says they've been investing heavily in its Taiwanese operation following October’s £9.3mln fundraise, formulating ink samples to potential customers' specifications for the US$15bn self-monitoring blood glucose market.

 
Meet Alliance Pharma PLC, IXICO PLC, Benchmark Holdings PLC, Clinigen Group PLC and Shield Therapeutics PLC at our event, London , 24 January 2019. Register here »
View full HAYD profile View Profile

Haydale Graphene Industries PLC Timeline

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use